Florida Recognizes Men’s Health Week

Men’s Health Week

Florida Department of Health joins county health departments around the state in celebrating Men’s Health Week June 11th-17th.

Created to increase awareness of preventable health problems and encourage early detection and treatment of diseases in men, Men’s Health Week is observed around the country to promote positive health behaviors in American men.

“Florida’s men are our fathers and brothers, husbands, sons, and co-workers so men’s health is an issue that truly impacts everyone,” Ana M. Viamonte Ros M.D., M.P.H., Secretary of Health and Florida’s State Surgeon General said. “This week, we encourage Florida’s men and the people who love them to learn about the issues that affect men’s health, and understand how to protect themselves by practicing a healthy lifestyle.”

In 2005, 40.6 percent of Florida men had high cholesterol and 9 percent were diagnosed with diabetes. Only 26 percent of Florida men consumed five fruits or vegetables a day in 2005 and less than 28 percent had twenty minutes or more of vigorous physical activity three or more days a week.

Men in Florida can take responsibility for their own personal health outcomes by engaging in preventative health behaviors. DOH encourages all male Floridians to use this week to schedule routine visits with their health care professionals and receive preventative exams and screenings for heart disease, diabetes, cancer, sexually transmitted diseases and dental care. In addition, throughout the year men should promote good health by maintaining a healthy diet, engaging in daily physical activity, receiving appropriate vaccinations, not smoking and managing stress.


Tests and Treatment for Low Testosterone

Tests for Testosterone Levels

If you are� � having the symptoms of low testosterone, talk to your doctor. You can get your testosterone level tested. It’s a simple blood test. Get the test in the morning, when the testes release more testosterone. Because a normal level of testerosterone is different for each man, it may be hard to know if you have low testorsterone–it helps if you had a testosterone test earlier in your life, so you’ll be able to see any change. If you do have low testosterone, think about visiting a specialized doctor, like an endocrinologist or urologist, who can work with you to treat this problem.

Treatment for Low Testosterone

We don’t know if testosterone therapy is safe.

The use of testosterone therapy is getting increasingly popular. But there are many things about this treatment that we don’t yet know:

  • We don’t know if testosterone therapy relieves symptoms of men with low testosterone.


  • We don’t know how low testosterone levels affect men’s health.


  • We don’t know if testosterone therapy increases the risk of prostate cancer.


  • We don’t know if testosterone therapy is safe.

Testosterone replacement therapy is an option for men whose natural testosterone level is not within the normal range. Talk to your doctor to find out if testosterone therapy is the right treatment for you. TRT comes in these forms:

Skin Patch . Applied daily to the upper arm, back, thigh, scrotum, or abdomen. It’s easy to use, and you maintain a balanced amount of testosterone in your body. Your skin could get irritated from the patch. In some men, the testosterone doesn’t get absorbed well through the skin.

Injections (shots). Injections are given either every week or every two to three weeks. The cost is low. You will need to visit your doctor for injections. With injections, your symptoms of low testosterone may fluctuate because it creates abnormal highs and lows in hormone levels.

Testosterone Buccal System . You place a tablet in the upper gum area of the mouth. It sticks to your gum or cheek. It stays in place for 12 hours and releases testosterone into your body. The tablet can fall off and shouldn’t be chewed or swallowed.

Gel . Applied daily to the skin on the shoulders, upper arms, and abdomen. It’s easy to use, and you maintain a balanced amount of testosterone in your body. In some men, the testosterone doesn’t get absorbed well through the skin.

Oral preparations of testosterone . This is rarely prescribed because it can severely damage the liver.

Treatment of Men with Erectile Dysfunction Improves Women’s Sexual Function and Satisfaction

Treatment for Erectile Dysfunction

Couples Share Sexual Problems and Solutions

Couples share wine, movies, vacations and bedrooms.� � Do couples also share sexual problems and solutions?� � In the November issue of The Journal of Sexual Medicine, researchers have published the first-ever prospective, double-blind, placebo-controlled, multi-institutional treatment study with multi-dimensional psychometrically valid outcomes and concluded that an effective erectile dysfunction treatment in men also significantly improved sexual function and sexual satisfaction in untreated women partners.� � The research concluded that women partners’ sexual function improvements related significantly and consistently to treatment-related improvements in men’s erectile function.� � Furthermore, erectile dysfunction management should acknowledge that both members of the couple may be affected by erectile dysfunction and its treatment.

The research, in an article entitled: “Women’s Sexual Function Improves When Partners Are Administered Vardenafil for Erectile Dysfunction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial,” published in The Journal of Sexual Medicine, involved 229 men with erectile dysfunction and their women partners for more than 6 months.� � The women completed baseline sexual function questionnaires including the Female Sexual Function Index, which has 19 questions concerning 6 domains: desire, arousal, lubrication, orgasm, satisfaction, and pain.� � Other outcome scales used included the Sexual Life Quality Questionnaire.

The couples were divided into two groups, those couples in which the men with erectile dysfunction received a safe and effective PDE5 inhibitor (vardenafil, Levitra) and those in which the men received placebo. There was no difference between the untreated women’s sexual function scores in the two groups at baseline.� � After 12 weeks and approximately 20 intercourse experiences, the untreated women who were with men assigned to placebo were observed to have their sexual function scores fall in all domains.� � The untreated women who were with men assigned to effective erectile dysfunction treatment recorded significantly increased sexual function scores in all domains.� � The greatest increases in sexual function were noted in orgasm and satisfaction domains.

In this landmark research, the physiological changes in sexual function of one member of the couple (the untreated woman) were found to be significantly linked to the physiological changes in sexual function of the other member of the couple (the treated man with erectile dysfunction).� � There are limited studies in medical literature where a physiological function of one individual not receiving treatment is improved when another individual receives treatment to improve a physiological function.

Dr. William Fisher, co-author of the study and Professor of Psychology, and Obstetrics and Gynecology at the University of Western Ontario in London, Canada, noted that “Erectile dysfunction has never been only about a man, a pill, and a penis. It is often the case that a partner’s sexual function suffers when a man experiences erectile dysfunction, and this research documents this fact and the welcome improvement of sexual function among women whose partners received effective treatment for their sexual problem.”

“The most fascinating aspect of this study,” said Dr. Irwin Goldstein, lead author of the research, “is that the women in the study were untreated and we observed that their physiology changed.� � Think of this for one minute.� � These are the first ever data that show physiologic changes in lubrication, orgasm and arousal in an individual who was NOT TREATED.”

The manuscript is published in The Journal of Sexual Medicine.

The Journal of Sexual Medicine is the official journal of the International Society for Sexual Medicine and its five regional affiliate societies.� � The aim of the journal is to publish multidisciplinary basic science and clinical research to define and understand the scientific basis of male and female sexual function and dysfunction. For more information on The Journal of Sexual Medicine , please visit http://jsm.issir.org

About The International Society for Sexual Medicine

Erectile dysfunction in diabetes is due to defect in brain

A new study sheds additional light on how erectile dysfunction (ED) interacts with diabetes. The study is another step in uncovering the link between the two disorders, and may lead to improved efficacy in erectile dysfunction treatments.

The study, “Lack of Central Nitric Oxide Triggers Erectile Dysfunction in Diabetes,” was conducted by Hong Zheng, William G. Mayhan, and Kaushik P. Patel, Departments of Cellular and Integrative Physiology; and Keshore R. Bidasee, Department of Pharmacology, University of Nebraska Medical Center, Omaha, NE. The results appear in the March 2007 edition of the American Journal of Physiology � � ” Regulatory, Integrative and Comparative Physiology, one of 11 peer-reviewed scientific publications issued monthly by The American Physiological Society (APS).

Erectile Dysfunction Background

Sexual dysfunction is a well-recognized consequence of diabetes mellitus in men. Erectile dysfunction, retrograde ejaculation and the loss of seminal emission have all been described by such patients. This study examined induced penile erection, yawning and stretch in diabetic rats. Male Sprague-Dawley rats treated with streptozotocin (STZ) to induce diabetes were used as they exhibit sexual and behavioral symptoms similar to those found in diabetic men with sexual dysfunction.

The researchers focused on the paraventricular nucleus (PVN) of the hypothalamus, located in the brain, an integration center between the central and peripheral nervous systems. The site is involved in numerous functions, including erectile function and sexual behavior, and is a primary site within the forebrain that has been implicated in penile erection. The investigators also examined central nitric oxide (NO within the PVN) which plays an important role in the neurotransmission of normal penile erection.

Penile erection is a behavioral response that occurs in response to the administration of N-methyl-D-aspartic acid (NMDA) within the PVN. At the same time, inhibition of NO synthase with NG-monomethly-L-argining (L-NMMA) prevents NMDA-induced erection. The researchers hypothesized that the blunted NMDA mediated responses in diabetes reflects an impaired NO mechanism within the PVN. The involvement of an NO mechanism in the NMDA mediated behavioral response was also explored.

The rats were exposed to a light/dark cycle, with standard temperature and humidity levels. The animals were randomly selected to receive chemical injection of the streptozotocin (STZ) to induce diabetes. Those rats that did not receive STZ (vehicle injected) served as controls. The experiments began on each of the rats four weeks after the injections.

Four experiments were conducted. Experiment one examined the effect of L-NMMA on NMDA mediated behavioral responses in normal rats; experiment two measured behavioral responses to NMDA or sodium nitroprusside (SNP), an NO donor in both control and diabetic rats; the third experiment observed the effect of diabetes on nNOS protein in the PVN; the fourth experiment measured NMDA mediated behavioral responses in diabetic rats after restoring the nNOS protein in the PVN using viral gene transfer.

Cialis Improves Sexual Function for Prostate Cancer Survivors

Cialis and Sexual Function

In the first randomized trial of its kind, Tadalafil, a drug typically prescribed for erectile dysfunction in men, has been proven to increase the sexual function of prostate cancer survivors, according to a study released today from the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO.

Prostate cancer is the most commonly diagnosed cancer in men, with an estimated 235,000 Americans expected to be diagnosed with it this year. In its early stage, prostate cancer can be treated with surgery and radiation therapy or a combination of the two. With more advanced cancer, treatment options can vary.

The walnut-sized prostate is located near the tubes that carry urine and semen. After treatment, some patients report trouble achieving an erection sufficient for sexual activity, also called erectile dysfunction or ED. In this study, doctors wanted to test whether the drug Tadalafil, which sells under the brand name Cialis, would help prostate cancer survivors with� � erectile dysfunction who were treated with three-dimensional conformal radiation therapy (3D-CRT). This is the first randomized, placebo-controlled, double-blind trial to examine Tadalafil’s lasting effect in treating patients who have� � erectile dysfunction after radiation therapy for prostate cancer.

Nearly 360 patients were treated for prostate cancer at the Erasmus MC-Daniel den Hoed Cancer Center in The Netherlands between 1998 and 2002. Among them, 60 patients complaining of erectile dysfunction after radiation therapy were included. Patients were eligible if they were treated with 3D-CRT at least 12 months before the study entry, agreed not to use any other treatment for� � erectile dysfunction and agreed to make at least one sexual intercourse attempt every week during the 12-week trial. Patients were given an initial 4-week course of no treatment at all; however, patients had to attempt sexual activity at least once a week in this 4-week period.

Patients were given 20mg of Tadalafil or a placebo for 6 weeks. Patients were allowed to take the drug or placebo at-will with no restrictions on food or alcohol, but no more than once per day. The men were instructed that the drug would be effective for as long as 36 hours after dosing. After the first 6-week period of the trial, participants were moved onto alternative treatment; patients who were given placebo were switched to Tadalafil and vice versa.

Doctors found that successful intercourse was reported in 48 percent of the survivors who took Tadalafil versus the 9 percent of the men who were given placebo. There was also a reported improvement of the quality of erections in 67 percent of the patients versus only 20 percent of the placebo group.

“Fortunately, prostate cancer is a very curable disease with most patients living at least five years after diagnosis. Now that we have� � proven we can beat the disease, it’s imperative that we work to help maintain the quality of life for the men who survive it, including preserving their sexual function,” said Luca Incrocci, M.D., Ph.D., lead author of the study. Dr. Incrocci is a radiation oncologist at the Erasmus MC-Daniel den Hoed Cancer Center in The Netherlands. “This study proves that the drug Cialis is effective in helping men maintain their sexual health.”